In October 2020, the Journal of Clinical Microbiology and Infection published the findings of a leading Covid-BioB study which found “Patients hospitalized with COVID-19 had a high incidence of secondary infections. At multivariable analysis, early need for ICU, respiratory failure, and severe lymphopenia, were identified as risk factors for secondary infections”.
Covid-19 patients are at a greater risk of secondary infections, including those derived from water such as legionnaire’s disease and other Pseudomonas bacteria. In respect of ACOP, L8 – Those responsible for designing, commissioning and managing water systems and associated equipment during this pandemic must ensure water systems do not pose a risk to these patients.
T-safe® are presently working with 33% of the NHS Trusts, providing our T-safe Medical point of use filters, thereby securing a physical barrier to the release of harmful bacteria originating from hospital water supply systems, protecting vulnerable Covid-19 patients from exposure to Legionella and Pseudomonas bacteria.
If you would like to learn more about how T-safe® can help you prevent infection from waterborne pathogens, or if you would like costs or product samples please do not hesitate to contact us.